2008 annual financial data
Anika Therapeutics 2008 Operating margin
Direct answer
Operating margin was 11.81%.
Operating income was 4,226,729 USD and net income was 3,629,195 USD.
Operating cash flow was 3,407,231 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,779,787 USD
- Operating income
- 4,226,729 USD
- Net income
- 3,629,195 USD
- Operating cash flow
- 3,407,231 USD